Ticker

No recent analyst price targets found for SFT.

Latest News for SFT

Vanda Pharmaceuticals Calls for Stronger FDA Action to Accelerate Shift from Animal Testing to Human-Relevant Methods

WASHINGTON, March 19, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), a leader in innovative drug development and a vocal advocate for reducing unnecessary animal testing, today voiced serious concerns over the U.S. Food and Drug Administration (FDA)'s new draft guidance, "General Considerations for the Use of New Approach Methodologies in Drug Development," released March 18, 2026, by the…

PRNewsWire • Mar 19, 2026
Shift Into Realism. Introducing the Logitech G RS H-Shifter

LAUSANNE, Switzerland & SAN JOSE, Calif.--(BUSINESS WIRE)--Logitech G today announced the long-anticipated RS H-Shifter, the latest addition to the renowned Racing Series Ecosystem. Designed to deliver unmatched realism, tactile control, and game-changing durability, this advanced 7+R manual shifter is tailor-made for anyone passionate about authentic racing experiences. For years, racers have yearned for a product…

Business Wire • Mar 17, 2026
REITs May Be The Biggest Winner Of The Coming Market Shift

AI is beginning to disrupt far more industries than most investors expected. As barriers to entry collapse, many businesses could face lower growth and valuations. But one asset class may actually benefit from this shift.

Seeking Alpha • Mar 14, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for SFT.

No House trades found for SFT.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top